The company, which filed for bankruptcy protection in 2017, stands to benefit from growing support for nuclear power and President Trump’s deal with Saudi Arabia.
Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.